Gilead Sciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABBV
AbbVie Inc. |
$173.02 | $299.17 B | 50.57 | 50000 | $54.32 B |
AMGN
Amgen Inc. |
$270.43 | $163.62 B | 43.57 | 26700 | $28.19 B |
AZN
AstraZeneca PLC |
$65.46 | $248.10 B | 39.42 | 89900 | $45.81 B |
BMY
Bristol-Myers Squibb Company |
$55.87 | $84.08 B | -13.38 | 34100 | $45.01 B |
JNJ
Johnson & Johnson |
$145.19 | $353.97 B | 21.85 | 131900 | $85.16 B |
LLY
Eli Lilly and Company |
$745.35 | $807.83 B | 125.37 | 43000 | $34.12 B |
MRK
Merck & Co., Inc. |
$99.95 | $330.96 B | 143.59 | 70000 | $60.12 B |
PFE
Pfizer Inc. |
$26.54 | $161.95 B | -571.6 | 88000 | $58.50 B |